Serina Therapeutics, Inc.
SER· NYSE
Released May 12, 2023, after the close
10-Q filed May 12, 2023, 42 days after period end · 0001493152-23-016642
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $30.00K | $5.00K | $56.00K | $89.00K |
| Net Income | $1.66M | -$2.71M | -$2.09M | -$3.19M |
| EPS Diluted |
Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR
| $0.20 |
| — |
| -$0.06 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.